acyclovir
- Product NDC
- 70518-1332
- 11-digit product format
- 705181332
- Labeler code
- 70518
- Product ID
- 70518-1332_e3c767ec-60df-6be0-e053-2995a90a3e05
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA204314
- Marketing category
- ANDA
- Marketing start
- 2018-07-30
- Marketing end
- 0000-00-00
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-1332-1 | 70518133201 | 21 TABLET in 1 BOTTLE, PLASTIC (70518-1332-1) | 21 tablet | 2018-08-08 | 0000-00-00 | No | No | Current |
| 70518-1332-2 | 70518133202 | 30 TABLET in 1 BLISTER PACK (70518-1332-2) | 30 tablet | 2018-08-22 | 0000-00-00 | No | No | Current |